SEC Form 4 · accession 0001171843-16-007470
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve E Wheeler
Director
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 26, 2016 | M | 1,770 | $10.51 | A | 31,122 | D | |
| Common StockF2 | Jan 26, 2016 | F | 486 | $38.33 | D | 30,636 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $10.51 | Jan 26, 2016 | M | 1,770 | D | — | Jan 26, 2016 | Common Stock | 1,770 | 0 | D |
Explanation of responses
- F1Exercise of stock appreciation rights ("SARs") granted on January 26, 2006, which vested in full immediately on such date, and expiring on January 26, 2016.
- F2Reflects 486 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on January 26, 2016.